Filing Details
- Accession Number:
- 0001209191-20-019140
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-16 12:51:36
- Reporting Period:
- 2020-03-12
- Accepted Time:
- 2020-03-16 12:51:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1509463 | A. Michael Sherman | 2505 Meridian Parkway, Suite 100 Durham NC 27713 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-03-12 | 72,995 | $1.45 | 102,995 | No | 4 | P | Indirect | By Sherman Investors LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Sherman Investors LLC |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,690 | Direct |
Footnotes
- The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.37 to $1.41, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- Includes 4,690 shares of Common Stock that were acquired by the Reporting Person on March 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan.